{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:18:17Z","timestamp":1790961497190,"version":"4.1.0"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005270","name":"Fujian Provincial Department of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005270","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p>Borderline ovarian tumors (BOTs), which are a special type of epithelial tumor of the ovary, lie between benign and malignant tumors and have low malignant potential. Due to the fact that the early symptoms of these tumors are relatively subtle, they are not easy to diagnose clinically. This study explores advancements in clinical detection methods and provides a comprehensive overview of molecules such as cell migration factors, cell transcription factors, cell damage repair factors, cell cycle regulators, and tumor suppressor genes that are related to the development of BOTs and their related mechanisms in recent years, thus aiming to provide more sensitive, specific, and efficient differential diagnosis and treatment plans for patients to improve their prognosis and survival outcomes.<\/jats:p>","DOI":"10.3389\/fmolb.2024.1429852","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T05:10:00Z","timestamp":1724994600000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Advances in understanding the molecular mechanisms of borderline ovarian tumors"],"prefix":"10.3389","volume":"11","author":[{"given":"Shiying","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meili","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumin","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuna","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13000-021-01158-4","article-title":"Aurora-A kinase is differentially expressed in the nucleus and cytoplasm in normal M\u00fcllerian epithelium and benign, borderline and malignant serous ovarian neoplasms","volume":"16","author":"Alkhateeb","year":"2021","journal-title":"Diagn. Pathol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"S55-S77","DOI":"10.1016\/j.semcancer.2015.02.005","article-title":"Evasion of anti-growth signaling: a key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds","volume":"35","author":"Amin","year":"2015","journal-title":"Seminars Cancer Biol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"4987","DOI":"10.1038\/onc.2011.653","article-title":"Sequential genetic change at the TP53 and chemokine receptor CXCR4 locus during transformation of human ovarian surface epithelium","volume":"31","author":"Archibald","year":"2012","journal-title":"Oncogene"},{"key":"B4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/PAT.0b013e32835bd561","article-title":"AGR2 expression in ovarian tumours: a potential biomarker for endometrioid and mucinous differentiation","volume":"45","author":"Armes","year":"2013","journal-title":"Pathology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jmig.2016.12.012","article-title":"Role of imaging tools for the diagnosis of borderline ovarian tumors: a systematic review and meta-analysis","volume":"24","author":"Borrelli","year":"2017","journal-title":"J. Minim. Invasive Gynecol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.ejogrb.2020.11.045","article-title":"Borderline ovarian tumors: guidelines from the French national college of obstetricians and gynecologists (CNGOF)","volume":"256","author":"Bourdel","year":"2021","journal-title":"Eur. J. Obstetrics and Gynecol. Reproductive Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.semcancer.2015.04.005","article-title":"Mechanisms of anterior gradient-2 regulation and function in cancer","volume":"33","author":"Brychtova","year":"2015","journal-title":"Seminars Cancer Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1538\/expanim.18-0103","article-title":"A rat model of serous borderline ovarian tumors induced by 7,12-dimethylbenz[a]anthracene","volume":"68","author":"Cai","year":"2019","journal-title":"Exp Anim."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.4161\/cc.10.13.16348","article-title":"Inhibition of Aurora-A kinase induces cell cycle arrest in epithelial ovarian cancer stem cells by affecting NF\u0138B pathway","volume":"10","author":"Chefetz","year":"2014","journal-title":"Cell Cycle"},{"key":"B10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.14670\/HH-11-902","article-title":"Expression of p53 and selected proliferative markers (Ki-67, MCM3, PCNA, and topoisomerase II\u03b1) in borderline ovarian tumors Correlation with clinicopathological features","volume":"33","author":"Ciepli\u0144ski","year":"2018","journal-title":"Histol. Histopathol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/978-0-387-68969-2_9","article-title":"Role of p53 and Rb in ovarian cancer","volume":"622","author":"Corney","year":"2008","journal-title":"Adv Exp Med Biol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1042\/CS20090537","article-title":"Increased plasma concentrations of anterior gradient 2 protein are positively associated with ovarian cancer","volume":"118","author":"Edgell","year":"2010","journal-title":"Clin. Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.2217\/bmm-2021-0144","article-title":"HOXA9-methylated DNA as a diagnostic biomarker of ovarian malignancy","volume":"15","author":"Faaborg","year":"2021","journal-title":"Biomark. Med."},{"key":"B14","first-page":"841","article-title":"LncRNA-HOST2 regulates cell biological behaviors in epithelial ovarian cancer through a mechanism involving microRNA let-7b","volume-title":"Hum. Mol. Genet.","author":"Gao","year":"2014"},{"key":"B15","doi-asserted-by":"publisher","first-page":"5098","DOI":"10.1038\/onc.2017.132","article-title":"Tumor-secreted anterior gradient-2 binds to VEGF and FGF2 and enhances their activities by promoting their homodimerization","volume":"36","author":"Guo","year":"2017","journal-title":"Oncogene"},{"key":"B16","doi-asserted-by":"publisher","first-page":"336","DOI":"10.5732\/cjc.010.10490","article-title":"Chemokine axes CXCL12\/CXCR4 and CXCL16\/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma","volume":"30","author":"Guo","year":"2011","journal-title":"Chin. J. Cancer"},{"key":"B17","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00109-014-1160-3","article-title":"ZNF281\/ZBP-99: a new player in epithelial\u2013mesenchymal transition, stemness, and cancer","volume":"92","author":"Hahn","year":"2014","journal-title":"J. Mol. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"31012","DOI":"10.1074\/jbc.M803547200","article-title":"Identification of aurora-A as a direct target of E2F3 during G2\/M cell cycle progression","volume":"283","author":"He","year":"2008","journal-title":"J. Biol. Chem."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.3892\/etm.2017.4118","article-title":"miR-9 functions as a tumor inhibitor of cell proliferation in epithelial ovarian cancer through targeting the SDF-1\/CXCR4 pathway","volume":"13","author":"He","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.3390\/ijerph18042167","article-title":"Serum free amino acid profiling in differential diagnosis of ovarian tumors\u2014a comparative study with review of the literature","volume":"18","author":"Horala","year":"2021","journal-title":"Environ. Res. Public Health"},{"key":"B21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13048-023-01106-4","article-title":"Combined use of CA125, neutrophil\/lymphocyte ratio and platelet\/lymphocyte ratio for the diagnosis of borderline and malignant epithelial ovarian tumors","volume":"16","author":"Huang","year":"2023","journal-title":"J. Ovarian Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3969\/j.issn.1674-4985","article-title":"Expression of HOST2 lncRNA in ovarian epithelial carcinoma and its clinical significance","volume":"12","author":"Jing","year":"2015","journal-title":"Med. Innovation China"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.4161\/cc.10.7.15231","article-title":"A minimally invasive assay for individual assessment of the ATM\/CHEK2\/p53 pathway activity","volume":"10","author":"Kabacik","year":"2011","journal-title":"Cell Cycle"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1172\/JCI62229","article-title":"HOXA9 promotes ovarian cancer growth by stimulating cancer-associated fibroblasts","volume":"122","author":"Ko","year":"2012","journal-title":"J. Clin. Investigation"},{"key":"B25","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.ajpath.2013.09.017","article-title":"Expression of the homeobox gene HOXA9 in ovarian cancer induces peritoneal macrophages to acquire an M2 tumor-promoting phenotype","volume":"184","author":"Ko","year":"2014","journal-title":"Am. J. Pathology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ygyno.2010.09.003","article-title":"Aurora-A overexpression and aneuploidy predict poor outcome in serous ovarian carcinoma","volume":"120","author":"Lassus","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s00404-020-05716-x","article-title":"Unilateral cystectomy and serous histology are associated with relapse in borderline ovarian tumor patients with fertility-sparing surgery: a systematic review and meta-analysis","volume":"302","author":"Li","year":"2020","journal-title":"Archives Gynecol. Obstetrics"},{"key":"B28","doi-asserted-by":"publisher","first-page":"596226","DOI":"10.3389\/fmed.2020.596226","article-title":"Role of retinoblastoma protein family (Rb\/p105 and Rb2\/p130) expression in the histopathological classification of borderline ovarian tumors","volume":"7","author":"Masciullo","year":"2020","journal-title":"Front. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e05000","DOI":"10.1016\/j.heliyon.2020.e05000","article-title":"Secretion of pro-oncogenic AGR2 protein in cancer","volume":"6","author":"Moidu","year":"2020","journal-title":"Heliyon"},{"key":"B30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.canlet.2019.01.025","article-title":"Anterior Gradient-2 monoclonal antibody inhibits lung cancer growth and metastasis by upregulating p53 pathway and without exerting any toxicological effects: a preclinical study","volume":"449","author":"Negi","year":"2019","journal-title":"Cancer Lett."},{"key":"B31","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12905-021-01263-y","article-title":"Recurrence characteristics and clinicopathological results of borderline ovarian tumors","volume":"21","author":"Niu","year":"2021","journal-title":"BMC Women's Health"},{"key":"B32","doi-asserted-by":"publisher","first-page":"7463","DOI":"10.1158\/0008-5472.CAN-11-2449","article-title":"PGE2-Induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment","volume":"71","author":"Obermajer","year":"2011","journal-title":"Cancer Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13053-022-00218-0","article-title":"Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor","volume":"20","author":"Ogrodniczak","year":"2022","journal-title":"Hered. Cancer Clin. Pract."},{"key":"B34","doi-asserted-by":"publisher","first-page":"696","DOI":"10.3858\/emm.2010.42.10.068","article-title":"IGF-1 induces expression of zinc-finger protein 143 in colon cancer cells through phosphatidylinositide 3-kinase and reactive oxygen species","volume":"42","author":"Paek","year":"2010","journal-title":"Exp. Mol. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1053\/hupa.2000.7641","article-title":"Overexpression of p21WAF1 CIP1 and MDM2 characterizes serous borderline ovarian tumors","volume":"31","author":"Palazzo","year":"2000","journal-title":"Hum. Pathol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/sj.bjc.6603581","article-title":"In ovarian cancer the prognostic influence of HER2\/neu is not dependent on the CXCR4\/SDF-1 signalling pathway","volume":"96","author":"Pils","year":"2007","journal-title":"Br. J. Cancer"},{"key":"B37","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.1002\/jmv.26664","article-title":"Evidence of human cytomegalovirus infection and expression of 5\u2010lipoxygenase in borderline ovarian tumors","volume":"93","author":"Rahbar","year":"2020","journal-title":"J. Med. Virology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13048-019-0501-9","article-title":"Expression of zinc finger transcription factors (ZNF143 and ZNF281) in serous borderline ovarian tumors and low-grade ovarian cancers","volume":"12","author":"Sadlecki","year":"2019","journal-title":"J. Ovarian Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1080\/01443615.2018.1499076","article-title":"Clinicopathological analysis of borderline ovarian tumours and risk factors related to recurrence: experience of single institution","volume":"39","author":"Sozen","year":"2018","journal-title":"J. Obstetrics Gynaecol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.ygyno.2020.01.027","article-title":"Association between pelvic inflammatory disease, infertility, ectopic pregnancy and the development of ovarian serous borderline tumor, mucinous borderline tumor and low-grade serous carcinoma","volume":"156","author":"Stewart","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3892\/or.2014.3243","article-title":"Aberrant hypomethylation-mediated AGR2 overexpression induces an aggressive phenotype in ovarian cancer cells","volume":"32","author":"Sung","year":"2014","journal-title":"Oncol. Rep."},{"key":"B42","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1186\/s12935-022-02767-9","article-title":"Role of HOXA9 in solid tumors: mechanistic insights and therapeutic potential","volume":"22","author":"Tang","year":"2022","journal-title":"Cancer Cell Int."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1158\/1078-0432.CCR-09-2329","article-title":"CXCL12 (SDF-1)\/CXCR4 pathway in cancer","volume":"16","author":"Teicher","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1136\/ijgc-2020-001451","article-title":"Ultrasound, macroscopic and histological features of borderline ovarian tumors","volume":"31","author":"Verdecchia","year":"2021","journal-title":"Int. J. Gynecol. Cancer"},{"key":"B45","doi-asserted-by":"publisher","first-page":"26616","DOI":"10.18632\/oncotarget.24299","article-title":"Association of genetic variants in ATR-CHEK1 and ATM-CHEK2 pathway genes with risk of colorectal cancer in a Chinese population","volume":"9","author":"Wang","year":"2018","journal-title":"Oncotarget"},{"key":"B46","doi-asserted-by":"publisher","first-page":"930220","DOI":"10.3389\/fonc.2022.930220","article-title":"FBXO9 mediates the cancer-promoting effects of ZNF143 by degrading FBXW7 and facilitates drug resistance in hepatocellular carcinoma","volume":"12","author":"Wang","year":"2022","journal-title":"Front. Oncol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"6241743","DOI":"10.1155\/2019\/6241743","article-title":"CPH-I and HE4 are more favorable than CA125 in differentiating borderline ovarian tumors from epithelial ovarian cancer at early stages","volume":"2019","author":"Wang","year":"2019","journal-title":"Dis. Markers"},{"key":"B48","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1159\/000495231","article-title":"Long noncoding RNA HOST2 promotes epithelial-mesenchymal transition, proliferation, invasion and migration of hepatocellular carcinoma cells by activating the JAK2-STAT3 signaling pathway","volume":"51","author":"Wu","year":"2018","journal-title":"Cell. Physiology Biochem."},{"key":"B49","doi-asserted-by":"publisher","first-page":"4131","DOI":"10.1080\/21691401.2019.1687496","article-title":"Sinomenine hydrochloride exerts antitumor outcome in ovarian cancer cells by inhibition of long non-coding RNA HOST2 expression","volume":"47","author":"Xu","year":"2019","journal-title":"Artif. Cells, Nanomedicine, Biotechnol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/j.1349-7006.2004.tb02195.x","article-title":"Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage","volume":"95","author":"Yoshida","year":"2004","journal-title":"Cancer Sci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.currproblcancer.2018.10.003","article-title":"Alteration of BRCA-1 tumor suppressor gene expression in serous and mucinous ovarian neoplasms in the benign-borderline-malignant pathway","volume":"43","author":"Yousif","year":"2019","journal-title":"Curr. Problems Cancer"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1158\/0008-5472.CAN-19-3226","article-title":"ZNF143-Mediated H3K9 trimethylation upregulates CDC6 by activating MDIG in hepatocellular carcinoma","volume":"80","author":"Zhang","year":"2020","journal-title":"Cancer Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3892\/ijmm.2018.3995","article-title":"Knockdown of long non-coding RNA HOST2 inhibits the proliferation of triple negative breast cancer via regulation of the let-7b\/CDK6 axis","volume":"43","author":"Zhang","year":"2018","journal-title":"Int. J. Mol. Med."}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2024.1429852\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T05:10:04Z","timestamp":1724994604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2024.1429852\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,30]]},"references-count":53,"alternative-id":["10.3389\/fmolb.2024.1429852"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2024.1429852","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,30]]},"article-number":"1429852"}}